Compare Mutual Funds
Pros | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 4/8 | 8/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 10 Months | 13 Years 10 Months | ||
Fund AUM | ₹1371 Cr | ₹9279 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.28% | 1% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 46 | 38 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 1 | 1 | ||
Top 3 Sectors | Health (100%) | Health (100%) | ||
Equity % | 97.08% | 97.32% | ||
Debt % | - | - | ||
P/E | 40.78 | 39.56 | ||
P/B | 5.72 | 5.84 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 2.71% | 1.12% | ||
3-Month Return | 13.1% | 9.07% | ||
6-Month Return | 21.12% | 12.24% | ||
1-Year Return | 20.05% | 14.06% | ||
3-Year Return | 25.36% | 19.73% | ||
5-Year Return | 16.38% | 13.85% |
Sharpe | 1.11 | 0.89 | ||
Alpha | 1.79 | -1.2 | ||
Beta | 0.96 | 0.88 | ||
Standard Deviation | 15.93 | 14.77 | ||
Information Ratio | 0.42 | -0.87 |
Description | UTI Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Kamal Gada | Amber Singhania, Kinjal Desai, Sailesh Raj Bhan |

